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Background: Metacaspases are multi-
functional cysteine peptidases. 
Results:  Trypanosoma brucei metacaspase 
4 is a catalytically inactive metacaspase 
homologue required for parasite virulence, 
which interacts with an active parasite 
metacaspase during release from the cell. 
Conclusion: Metacaspase 4 is a 
pseudopeptidase virulence factor.  
Significance: Extracellular release and 
proteolytic processing provide novel insights 
into metacaspase function. 
 
SUMMARY 
Metacaspases are caspase family cysteine 
peptidases found in plants, fungi and 
protozoa, but not mammals. Trypanosoma 
brucei is unusual in having five 
metacaspases (MCA1-MCA5) of which 
MCA1 and MCA4 have active site 
substitutions, making them possible non-
enzymatic homologues. Here we 
demonstrate that recombinant MCA4 
lacks detectable peptidase activity, despite 
maintaining a functional peptidase 
structure. MCA4 is expressed primarily 
in the bloodstream form of the parasite 
and associates with the flagellar 
membrane via dual myristoylation/ 
palmitoylation. Loss of function 
phenotyping revealed critical roles for 
MCA4; rapid depletion by RNAi caused 
lethal disruption to the parasite’s cell 
cycle, yet the generation of MCA4 null 
mutant parasites (∆mca4) was possible. 
∆mca4 had normal growth in axenic 
culture, but markedly reduced virulence 
in mice. Further analysis revealed that 
MCA4 is released from the parasite and is 
specifically processed by MCA3, the only 
metacaspase that is both palmitoylated 
and enzymatically active. Accordingly we 
have identified that the multiple 
metacaspases in T. brucei form a 
membrane-associated proteolytic cascade 
to generate a pseudopeptidase virulence 
factor. 
Metacaspases (MCAs) are clan CD, 
family C14B, cysteine peptidases identified 
in plants, fungi and protozoa (1). They are 
predicted to be structurally similar to 
caspases with a caspase/haemoglobinase 
fold and a canonical histidine and cysteine 
dyad in the active site (1). MCAs differ from 
caspases in that they lack Asp specificity 
having a strict  arginine or lysine substrate 
specificity, and many are activated by 
calcium (2-4). Many MCAs undergo 
autocatalytic processing of the zymogen to 
produce a mature enzyme, although this 
processing is not necessarily required for 
enzymatic activity (2,4,5). The natural 
targets of MCAs are uncertain, with the 
proteolytic cleavage of Picea abies Tudor 
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staphylococcal nuclease (TSN) by the MCA 
mcII-Pa during embryogenesis and induced 
programmed cell death being the only in 
vivo action reported to date (6). 
A seminal study that identified the 
Saccharomyces cerevisiae MCA (Yca1) as a 
positive regulator of programme cell death 
(7) sparked great interest and paved the way 
for many subsequent descriptions of 
additional pro-death roles for MCAs (8). 
However, sustained research on MCAs of 
various organisms has revealed that they 
represent a functionally diverse family of 
peptidases. The single MCAs of S. 
cerevisiae and Leishmania major apparently 
harbour a capacity for multi-functionality. 
Yca1 is implicated in both cell cycle 
regulation (9) and the clearance of insoluble 
protein aggregates (10), while the MCA of 
L. major (LmjMCA) is required for cell 
cycle progression (11) in addition to having 
a role in PCD induced by oxidative stress 
(12). Furthermore, the antagonistic 
relationship of two Arabidopsis thaliana 
MCAs in the hypersensitive response cell 
death pathway (AtMC1 promotes cell death, 
while AtMC2 functions as a negative 
regulator) reveals the potential of MCAs for 
complex connections in key regulatory 
processes (13). 
Trypanosoma brucei unusually has 
five MCA genes (MCA1-MCA5), only three 
of which (MCA2, MCA3 and MCA5) encode 
proteins with the canonical histidine-
cysteine catalytic dyad and are therefore 
predicted to be catalytically active (14,15). 
Investigation into these MCAs revealed 
collective essentiality for bloodstream form 
parasites; simultaneous RNAi depletion 
caused rapid cell death attributed to 
accumulation of abnormal cell types 
resulting from a pre-cytokinesis defect (16). 
Despite this severe phenotype resulting from 
RNAi, triple null mutant parasites 
(∆mca2/3∆mca5) were generated and had 
similar growth in axenic culture and mice, as 
in wild type parasites. While questions 
remain regarding the precise role of these 
MCAs it appears that they are not required 
for prostaglandin D2 induced programme 
cell death (16). However, the three MCAs 
were found to be associated with RAB11-
positive endosomes, even though they are 
not necessary for the known recycling 
processes performed by these endosomes 
(16). Deciphering the nature of this 
association could be pivotal to elucidating 
the main function(s) of these MCAs. 
An intriguing aspect of the T. brucei 
MCA family is the presence of the two 
genes predicted to encode catalytically 
inactive proteins: MCA1 lacks both the 
histidine and cysteine of the expected active 
site dyad, whereas MCA4 has a serine in 
place of the usual catalytic cysteine (14,15). 
Substitutions within the catalytic centre of 
enzyme homologues is widespread across 
protozoan and metazoan proteomes, and 
some non-enzymatic homologues have been 
shown to play key regulatory roles (17). 
Indeed, regulation of some peptidases is 
known to occur through related inactive 
homologues. For example, the activity of 
caspase-8 in the mammalian extrinsic 
apoptotic pathway is regulated by direct 
interaction with cFLIPL, an inactive caspase-
8 homologue (18). Also, growth factor 
signalling that is dependent on the 
intramembrane rhomboid peptidases is 
controlled by iRhoms (inactive rhomboid 
homologues) through substrate sequestration 
and subsequent removal via endoplasmic 
reticulum degradation (19). However, not all 
atypical active site configurations preclude 
peptidase activity, with mixed-catalytic type 
peptidases also capable of proteolysis. The 
poliovirus-type picornain C3 peptidases are 
instrumental in processing expressed viral 
proteins with proteolytic activity derived 
from a cysteine nucleophile operating within 
a classical serine peptidase fold (20). To date 
no proteins have been identified with 
proteolytic activity derived from a serine 
nucleophile in a caspase fold. 
Thus several possible roles for 
MCA4 could be envisaged and we 
undertook a detailed characterisation of the 
enzyme with the aim of elucidating the part 
it plays as a member of the T. brucei MCA 
family. We found that despite the potentially 
catalytic serine residue in the MCA4 active 
site, the recombinant enzyme lacked 
peptidase activity towards a combinatorial 
peptide library and the specific activity 
towards Arg/Lys residues characteristic of 
metacaspases and thus is a pseudopeptidase. 
In addition, reverse genetics revealed MCA4 
to have roles in both cell cycle progression 
and parasite virulence during mammalian 
infection. Moreover, we show that the 
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membrane-associated MCA4 is specifically 
processed during its release by the 
palmitoylated and so membrane-bound 
MCA3 and thus that they appear to comprise 
a MCA proteolytic cascade. 
 
EXPERIMENTAL PROCEDURES 
Plasmids - Unless otherwise stated 
all PCR reactions used T. brucei (strain 427) 
genomic DNA as an amplification template 
and all oligonucleotide sequences are listed 
in Supplementary Information Table S1. For 
MCA4 protein expression the coding 
sequence was amplified using OL2329 and 
OL2330 and cloned into the pET-28a(+) 
(Novagen) using NdeI and XhoI restriction 
sites, creating pGL1697. MCA4S219C protein 
expression plasmid was produced by site 
directed mutagenesis of MCA4 in pGL1697 
using OL2605 and OL2606. For the MCA4 
RNAi plasmid a unique 469 bp fragment 
was identified by TrypanoFAN:RNAit 
(http://trypanofan.path.cam.ac.uk/software/R
NAit) amplified using OL2312 and OL2313, 
and cloned into HindIII and BamHI sites in 
p2T7ti (21), creating pGL1695. For 
transfection into T. brucei pGL1695 was 
digested with NotI. For deletion of the 
MCA4 locus the 5’ and 3’ flanks of the 
MCA4 ORF were amplified by PCR using 
the primer pairs OL3245 (NotI) OL3246 
(XbaI) and OL3247 (ApaI) OL3248 (ApaI 
and XhoI), respectively. Using NotI/XbaI 
and ApaI/XhoI the 5’ and 3’ flanks were 
sequentially ligated into pGL1689, creating 
the NEO MCA4 knockout construct named 
pGL1986. Exchange of resistance genes was 
achieved by excising a HYG gene from 
pGL1688 using BmgBI and BglII and 
cloning into pGL1986 pre-digested with 
BmgBI and BglII, generating pGL1985 the 
HYG MCA4 knockout construct. For 
transfection into T. brucei pGL1986 and 
pGL1985 were digested with NotI and XhoI. 
The ectopic re-expression of MCA4 was 
achieved by modification of p2628 (22). 
Firstly the following primer pairs were used 
for site directed mutagenesis to introduced 
NdeI (OL3047, OL3048) and BclI (OL3046, 
OL3055) restriction sites flanking the HYG 
gene, thereby allowing replacement with a 
BSD gene, cloned from pGL1466 using 
OL3049 and OL3050. The resulting 
construct was digested with XhoI and 
BamHI (removing the YFP coding 
sequence) and the MCA4 gene amplified 
using OL3403 and OL3404 was cloned in 
producing pGL2067. For the ectopic 
expression of MCA4-YFP the same BSD re-
expression construct was digested with 
HindIII and BamHI allowing insertion of 
MCA4 cloned without the stop codon using 
OL3397 and OL3398 to create, pGL2132. 
For re-expression of mutant forms of 
MCA4, pGL2067 was subject to site 
directed mutagenesis. To investigate MCA4 
membrane association, a cytosolic MCA4 
mutant was generated by removing the 
predicted N-myristoylation site, using 
OL3768 and OL3769, creating MCA4G2A. 
The active site mutant MCA4S219C was 
produced using OL2605 and OL2606. All 
site directed mutagenesis alterations were 
made using the Quick Change Mutagenesis 
Kit (Stratagene) according to manufacturer’s 
instructions and confirmed by DNA 
sequencing. 
Parasites - T. brucei Lister 427 were 
grown in culture as bloodstream form to a 
maximum cell density of 1 x 106 ml-1 at 37°C 
in 5 % carbon dioxide in HMI-9 media 
supplemented with 10 % heat-inactivated 
foetal calf serum, 10 % serum plus and 0.5 
µg ml-1 penicillin-streptomycin solution 
(Sigma). Procyclic form were grown to a 
maximum cell density of 1 x 107 ml-1 at 
27°C in 5 % carbon dioxide in SDM-79 
medium supplemented with 10 % FCS and 
0.5 µg ml-1 penicillin-streptomycin solution 
(Sigma). The genetic knockout of MCA4 
was performed in bloodstream form T. 
brucei 427. The triple MCA null mutant cell 
line (∆mca2/3∆mca5) was generated and 
characterised previously (16). For animal 
infection assays, 1 x 105 cultured parasites 
were inoculated into ICR mice by intra 
peritoneal injection and the parasitemia 
monitored daily by haemocytometer cell 
count of mouse blood taken from a tail vein 
diluted in 0.83 % ammonium chloride. For 
infection experiments, groups of four mice 
were infected with trypanosomes taken 
directly from the same donor mouse. 
T. brucei transfection - 1 x 107 mid-
log cells were harvested by centrifugation at 
1500 g for 10 minutes at 37°C. The cell 
pellet was resuspended in 100 µl Human T 
Cell Nucleofector Solution (Lonza), 
transferred to an electroporation cuvette and 
mixed with 10 µg of linearised DNA and 
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pulsed once on programme X-001 using the 
Human T Cell Nucleofector machine 
(Amaxa). After overnight recovery, selection 
of clones was achieved by limiting dilution 
with appropriate antibiotics 5 μg ml-1 
hygromycin B (Calbiochem), 2.5 μg ml-1 
G418 (Calbiochem), 2.5 μg ml-1 phleomycin 
(InvivoGen) and 10 μg ml-1 blasticidin 
(Calbiochem). RNAi analysis and the 
tetracycline induced expression of tagged 
transgenes was performed in bloodstream 
form 427 13-90 and procyclic form 427 29-
13 cell lines (23). To induce RNAi or 
transgene expression 1 μg ml-1 tetracycline 
was added to the culture medium, with cells 
re-seeded at 1 x 105 ml-1 every 24 hours.  
Fluorescence activated cell sorting 
(FACS) - To analyse the DNA content of T. 
brucei, cells were fixed overnight in 70% 
methanol 30% PBS, washed in 10 ml PBS 
and resuspended in 1ml of PBS 
supplemented with 10 μg ml-1 propidium 
iodide (Sigma), 10 μg ml-1 RNAse A 
(Sigma) and incubated at 37°C for 45 
minutes, in the dark. FACS analysis was 
performed on a Becton Dickinson 
FACSCalibur. For each sample, 10,000 
events (cells) were analysed. Data 
interpretation was performed using the 
CellQuestPro software (BD Biosciences). 
Recombinant protein: expression 
and purification - The MCA4 protein 
expression vector (pGL1697) was 
transformed into BL21 Rosetta Escherichia 
coli (Stratagene) and bacteria were grown in 
Overnight Express TB Medium (Novagen) 
for 16 hours and lysed in Bacterial Protein 
Extraction Reagent (Pierce) supplemented 
with 10 μg ml-1 DNAse 1 (Sigma). HIS-
MCA4 was purified by immobilised metal 
ion affinity chromatography on a column 
packed with Metal Chelate-20 (Poros). 
MCA4 was eluted in 1 ml fractions using 50 
mM NaH2PO4, 300 mM NaCl, 0.5 M 
Imidazole pH 8.0, then buffer exchanged 
into 50 mM Tris pH 8 using a PD10 column 
(GE Healthcare) and 150 mM NaCl 
subsequently added. 
Antibody production - Purified 
recombinant MCA4 was used as an antigen 
to raise a polyclonal antibody. Two chickens 
were immunised with recombinant MCA4 
(four 250 μl inoculations of 1 mg ml-1 
protein over four months) at the Scottish 
National Blood Transfusion Service 
(Penicuik, Midlothian). Total IgY was 
purified from egg yolks using the Eggcellent 
IgY Purification kit (Pierce), then affinity 
purified against recombinant MCA4 
immobilised on AminoLink Coupling Gel 
(Pierce) according to manufacturer’s 
instructions.  
Immunoblotting - Whole cell 
extracts and purified proteins were mixed 
with LDS Sample Buffer (Invitrogen), 
denatured by heating at 100oC for 4 minutes, 
then electrophoresed on 12 % (w/v) SDS-
PAGE. Gels were either stained with 
Coomassie Brilliant Blue R-250 (2.5 % 
(w/v)), 45 % (v/v) methanol, 10 % acetic 
acid) or transferred to nitrocellulose 
membrane (Hybond-C, Amersham 
Biosciences) for western blotting. Primary 
antibodies against MCA4, EF-1α 
(Millipore), Bip (gift from J.D.Bangs 
University of Wisconsin, Madison, WI, 
USA) were used at 1:800, 1:2000 and 
1:15000 respectively. HRP-conjugated anti-
chicken (Invitrogen) was used at 1:4000 and  
anti-mouse (Promega), anti-rabbit (Promega) 
and anti-sheep (Santa Cruz) were used at 
1:5000. The cellular fractionation was 
verified using antibodies specific to the 
cytoskeletal protein β-tubulin (24) (KMX-1 
monoclonal Millipore) diluted 1:10,000 and 
the cytoplasmic protein oligopeptidase B 
1:1000 (25-27). Chemiluminescence 
detection was with the SuperSignal system 
or Novex ECL (Invitrogen).  
Enzyme Assays - For autocatalytic 
processing 10 μg of purified recombinant 
MCA4 or MCA4S219C was incubated in a 
reaction buffer (50mM Tris-HCl, pH 8, 150 
mM NaCl, 5 mM DTT) with and without 10 
mM CaCl2 for 1 hour at 37oC. For MCA3 
autocatalytic processing 5 μg of recombinant 
enzyme was incubated in described buffer 
supplemented with 1 mM CaCl2. The extent 
of autocatalytic processing was monitored 
by SDS-PAGE.  For MCA2 processing of 
MCA4 10 μg of purified MCA4 was 
incubated with increasing amounts of 
purified recombinant MCA2 (0, 1, 10 and 
100 ng) in reaction buffer (50mM Tris-HCl, 
pH 8, 150 mM NaCl, 5 mM DTT, 10 mM 
CaCl2) for 1 hour at 37oC. The extent of 
processing was monitored by SDS-PAGE. 
Fluorogenic enzyme assays - 
Proteolytic activity of purified recombinant 
protein was assessed by measuring the 
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hydrolysis of synthetic fluorogenic 
substrates. All assays were run in clear 
bottom 96 well plates and typically 
contained the following components: 2 μg 
purified enzyme, reaction buffer (50mM 
Tris-HCl, pH 8, 150 mM NaCl, 5 mM DTT 
and 10 mM CaCl2), 10 μM substrate (e.g. Z-
RR-AMC) and distilled water to 200 μl. All 
assays were run in triplicate and included 
‘no-enzyme’ controls. Fluorescence was 
read in an EnVision Multilabel Reader 
(Perkin Elmer, Beaconfield, UK) at 
excitation wavelength (λEx) of 355 nm and 
emission wavelength (λEm) of 460 nm using 
the general mirror. Specific activities were 
calculated using a 7-amino-4-
methylcoumarin standard (AMC). A 
positional-scanning combinatorial library 
was used to confirm the lack of MCA4 
activity; Abz-GXXZXXQ-EDDnp, where 
Abz is ortho-aminobenzoic acid, Q-EDDnp 
is glutamine (ethylene diamine [2,4-
dinitrophenyl]), the Z position was filled 
with 1 of 19 amino acids (cysteine was 
omitted), and X represents randomly 
incorporated amino acids. 
Acyl-biotin exchange - To detect 
MCA4 palmitoylation an acyl biotin 
exchange assay was used as previously 
described by Emmer and co-workers (28). 
N-terminal Edman degradation - To 
sequence the N-terminus of processing 
products reactions were set up as described 
above, electrophoresed on NuPAGE Novex 
10 % Bis-Tris gels (Invitrogen) and 
transferred to a PVDF membrane (Hybond-
P, Amersham Biosciences). Edman 
sequencing was performed by the University 
of Dundee, MRC Protein Phosphorylation 
Unit.  
Microscopy - Images were obtained 
using an Applied Precision DeltaVision 
Deconvolution microscope system fitted 
with a CoolSnap HQ camera. Image capture 
and microscope operation was performed 
using the software package SoftWoRx. 
Fluorescence was viewed using the FITC 
filter (λEx 490 nm / λEm 528 nm), RD-TR-PE 
filter (λEx 555 nm / λEm 617 nm), DAPI filter 
(λEx 360 nm / λEm 457  nm) and reference 
images were obtained using the differential 
interference contrast (DIC) filter. Exposure 
time was set to 1 second with the 
transmission level of the neutral filter 
optimised for each sample and 60x or 100x 
oil immersion objectives were used. 
Typically 15 Z-stacks were obtained and 
individually deconvolved using the 
automatic conservative ratio setting before 
projection into one representative image. To 
merge images containing multiple 
fluorescent signals Adobe photoshop was 
used. For direct cell fluorescence, 
approximately 1 x 105 T. brucei were 
washed twice in trypanosome dilution buffer 
(TDB) (20 mM Na2HPO4, 2 mM NaH2PO4, 
80 mM NaCl, 5 mM KCl, 1 mM MgSO4, 20 
mM glucose, pH 7.4) before fixation in 1 % 
(w/v) paraformaldehyde (Sigma) with 
concurrent incubation on ice for 15 minutes. 
After two further washes in TDB the cell 
pellet was resuspended in 20 µl TDB and 
evenly spread onto twin frosted end 76 x 26 
mm microscope slide coated in 0.1 % poly-l-
lysine (Sigma) and the cells allowed to 
sediment. Excess liquid was removed and 
the cells on each slide were stained with 10 
μl of 1 μg ml-1 4,6-Diamindino-2-
phenylindole (DAPI) in mounting solution 
(PBS, 50 % (v/v) glycerol, 2.5 % (w/v) 
DABCO). All slides were fitted with a 
coverslip sealed with nail varnish. 
Immunofluorescence analysis - The 
protocol used for immunofluorescence 
analysis was adapted from the method 
published by Field and co-workers (29). 
Briefly, mid-log bloodstream form parasites 
were washed in vPBS (137 mM NaCl, 3 mM 
KCl, 16 mM Na2HPO4, 3 mM KH2PO4, 46 
mM sucrose, 10 mM glucose, pH 7.6) before 
fixation on ice in 3 % paraformaldehyde for 
10 minutes. The fix solution was diluted out 
with excess vPBS and two further cell 
washes were performed. Fixed cells were 
applied to a 2 cm2 area outlined in nail 
varnish, on 0.1 % poly-l-lysine treated 
microscope slides and allowed to sediment. 
When required the cells were permeabilised 
by applying 0.1 % (v/v) Triton X-100 in 
PBS for 10 minutes before washing with 
PBS and blocking for 1 hour using 20 % 
(v/v) foetal calf serum (Sigma) in PBS. Anti-
MCA4 (1:400) diluted in blocking solution 
was applied and incubated for 2 hours at 
room temperature. Slides were washed three 
times with PBS before one incubation with 
Alexa Fluor 488 (green)-conjugated anti-
chicken (Molecular Probes) diluted 1:7500 
in blocking solution. Slides were washed 
three times with PBS, stained with 1 μg ml-1 
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DAPI in mounting solution and sealed with 
a coverslip and nail varnish. 
Immunoelectron microscopy - A 
bloodstream form T. brucei cell pellet was 
chemically fixed in suspension and 
maintained in 0.2 % (v/v) gluteraldehyde, 2 
% (w/v) paraformaldehyde in PBS (pH 7.2) 
on ice for 1 hour. After fixation the cells 
were rinsed in PBS and embedded in 
Lowicryl resin using the progressive 
lowering of the temperature method. Cells 
were cut into blocks and mounted on metal 
pins and frozen in liquid nitrogen before 
sectioning with a Leica Ultracut UCT/FCS. 
The cryosections were blocked with 0.1 M 
glycine followed by 5 % (w/v) BSA and 
then labelled with affinity purified anti-
MCA4 (1:10) and 1.4 nm gold (rabbit) anti-
chicken (1:20) (Aurion). Cells were contrast 
stained and the immuno-labelling was 
enhanced by 15 minutes treatment with R-
gent (Aurion). Sections were viewed with a 
LEO 912 transmission electron microscope. 
Cell fractionation - The cellular 
fractionation method was adapted from (30). 
For detergent lysis 2 x 107 mid-log cells 
were washed in vPBS and lysed in 500 μl 
1% (v/v) Triton X-100, 25mM HEPES, 
1mM EDTA pH7.4 for 30 mins on ice 
before centrifugation at 14,000 g for 5 min. 
For hypotonic lysis 2 x 107 mid-log BSF 
cells were washed in vPBS and lysed in 500 
μl 10mM Tris-HCl pH7.4 with 4 x 15 
second blasts in an ice cold sonicating water 
bath (Fisher Scientific FB15047), before 
centrifugation at 14,000 g for 5 minutes. For 
both lysis methods, insoluble material in the 
pellet was solubilised by boiling with 625 μl 
1 x SDS-PAGE sample buffer for 5 min. 
The supernatant was prepared for 
electrophoresis by adding 125 μl 4 x SDS-
PAGE sample buffer and boiling for 5 min. 
1 x 106 cell equivalents were loaded per 
lane.  
Motility analysis - T. brucei 
resistance to sedimentation was investigated 
as a function of cell motility (31). Wild type 
BSF T. brucei and Δmca4 cells were 
cultured to the same mid-log densities. 2 ml 
of culture was divided equally into 2 
cuvettes and the OD600 was recorded at 0, 3 
and 6 hour time points. One cuvette 
remained undisturbed and the other mixed 
and re-suspended before each optical density 
reading. Three replicate experiments were 
performed and sedimentation rates 
determined by subtracting the OD600 of the 
undisturbed control from the OD600 of the 
resuspended culture. 
MCA4 Release - To detect release of 
MCA4 1 x 108 mid-log T. brucei cells were 
washed in TDB and incubated at 37oC in 15 
ml 50% serum free HMI9 50% TDB. Cell 
viability was monitored every hour by 
haemocytometer count and after 3.5 hours 
cells were removed by centrifugation at 
1500 x g for 15 minutes. Trypanosome free 
medium was carefully aspirated and 
Complete Protease Inhibitor Cocktail 
(Roche) added to final concentration of 1.5 
x, before slow passage through 0.2 μm 
syringe filter and 75-fold concentration 
using a VivaSpin 20 10,000 MWCO filter 
unit. The concentrated supernatant was 
prepared for SDS-PAGE and 35 µl loaded 
alongside whole cell lysate from 1 x 105 
cells and electrophoresed on a 12% SDS-
PAGE, then transferred to nitrocellulose for 
western blotting. 
Statistical analysis of data - Where 
indicated data were expressed as means ± 
standard deviation from the mean. P-values 
were calculated using an unpaired, two-
tailed Student’s T-test on Microsoft Excel. 
Differences were considered significant at a 
p-value of <0.001. 
 
RESULTS 
MCA4 is a pseudopeptidase - The 
predicted active site of MCA4 maintains the 
canonical histidine residue but has serine 
instead of the usual cysteine nucleophile 
(14,15). Given the highly specific nature of 
enzyme active sites, it seemed likely that this 
substitution would make the peptidase 
inactive. However, other possibilities 
existed. Firstly, it is possible MCA4 
functions as a mixed-type peptidase utilising 
the reactive hydroxyl group of the serine as a 
nucleophile. Secondly, two cysteine residues 
widely conserved amongst MCAs but 
located outside of the predicted active site 
may serve as alternative catalytic residues; 
MCA4 Cys98 is found in all MCAs and 
MCA4 Cys218 is present in all kinetoplast 
MCAs (14,32). Thus, we first sought to 
establish whether or not MCA4 is an active 
peptidase through analysis of the 
recombinant protein. 
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Previous work demonstrated that 
TbMCA2 undergoes rapid calcium-
dependent autocatalytic processing but that 
this is not required for activity (2). MCA4 
remained unprocessed in the presence of 
calcium (Fig. 1A) and a range of peptide 
substrates cleaved by MCA2, including Z-
GGR-AMC, Z-GRR-AMC, Z-RR-AMC and 
a peptide library containing all amino acids 
in the P1 position, also failed to detect 
MCA4 activity. An MCA4S219C mutant, in 
which the active site serine was replaced 
with cysteine, was, however, capable of 
autoprocessing when incubated with calcium 
(Fig. 1B). N-terminal Edman sequencing of 
the major proteolytic processing product 
identified autocatalytic cleavage at Lys64 
(KESK64GFQPWK). Consistent with 
metacaspase-specificity towards basic 
residues in the P1 position we found that 
MCA4S219C could also cleave the peptide 
substrate Z-GGR-AMC, although at a rate 
greatly reduced in comparison to MCA2 
(MCA2 11 ± 3.0; MCA4S219C 0.031 ± 0.0043 
mU/mg protein). MCA4S219C activity was 
similar to that of MCA2 in being dependent 
on calcium and strongly inhibited by 
leupeptin and antipain but only mildly 
inhibited by E64 (Fig. 1C). These data 
collectively demonstrate that creation of the 
canonical metacaspase-dyad in MCA4 
produces a calcium-dependent 
proteolytically active enzyme, confirming 
that MCA4 has retained the structure of 
active MCAs; the lack of peptidase activity, 
however, means that it is a pseudopeptidase. 
RNAi depletion of MCA4 severely 
restricts parasite proliferation - Western 
blot analysis revealed that MCA4 expression 
has a distinct stage-specificity, with the 
protein being present in the bloodstream 
form but not detectable in the procyclic form 
of the parasite (Fig. 2A). The antibody 
specificity was confirmed by analysis of an 
MCA2, MCA3, MCA5 triple null mutant 
(16), in which the immunopositive band was 
similar in intensity to that in wild type 
parasites (Fig. 2A). The size of the MCA4 
protein in the parasite extracts was very 
close to the predicted 40 kDa molecular 
mass of the full length protein, showing that 
under standard in vitro growth conditions 
MCA4 in the parasite was not subject to 
detectable proteolytic processing events. 
This defined pattern of expression 
suggested an important role specific to 
bloodstream forms, so in order to investigate 
this we characterized the effects of targeted 
RNAi downregulation of MCA4 in this life 
cycle stage. Following RNAi induction, a 
rapid growth arrest occurred at around 8 
hours with only low numbers of motile cells 
persisting over the remainder of the RNAi 
time course (Fig. 2B). Western blot analysis 
was used to verify the successful depletion 
of MCA4 (Fig. 2C). To analyse the 
progression of RNAi-induced parasites 
through the cell cycle, the configuration of 
nuclei (N) and kinetoplasts (K) was 
determined by fluorescent microscopy of 
DAPI-stained cells (Fig. 2D). The reduction 
of cells with one nucleus and one kinetoplast 
(1N1K cells) with increased 2N2K and 
abnormal cells (classified as ‘others’ 
including those containing increased DNA 
content and zoids) showed that induced cells 
were able to replicate their DNA but failed 
to correctly execute cytokinesis. The flow 
cytometry profiles of the induced cells 
confirmed the DAPI analysis (Fig. S1). 
These RNAi data suggest that MCA4 is 
essential for the normal proliferation of 
bloodstream form T. brucei. This finding 
corroborates and expands upon a similar 
observation following a genome-wide RNAi 
silencing screen which identified MCA4 as 
having a loss of fitness phenotype (33). 
An important role for MCA4 in 
virulence - Previous work demonstrated that 
simultaneous RNAi silencing of MCA2, 
MCA3 and MCA5 was lethal to bloodstream 
form T. brucei, yet the generation of triple 
null mutant cell lines was still possible (16). 
We found this was also the case with 
MCA4, as MCA4 null mutants (Δmca4) 
were readily generated. MCA4 and a number 
of mutant MCA4 re-expression lines were 
created through introduction of specific 
amino acid changes within MCA4 
(designated Δmca4:MCA4, Δmca4:MCA4G2A 
and Δmca4:MCA4S219C). The validity of the 
genetic manipulation was confirmed by 
Southern blotting (Fig. S2) and western 
blotting was used to verify the absence of 
MCA4 in Δmca4 cells and to demonstrate 
re-expression occurred at an equivalent level 
to the wild type cells (Fig. 3A). 
The initial growth rate of Δmca4 
parasites in culture was greatly reduced in 
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comparison with the parental wild type 
strain (Fig. S3). However, following several 
weeks of continuous growth and sub-
culturing, the growth rate of Δmca4 
recovered and DAPI analysis revealed that, 
unlike the RNAi-induced cells, no major 
defects were detected in cell cycle 
progression or motility (Fig. S3). 
A potential role of MCA4 in the 
mammalian infection process was 
investigated by comparing the infection 
profiles of wild type and mutant parasites in 
mice. The wild type parasites were highly 
virulent in mice and by day 4 established 
parasitemia above 108 cells ml-1, which was 
when the mice were culled (Figs. 3B and 
3C). Δmca4 parasites, however, showed a 
drastically different infection profile, with 
mouse survival prolonged to around 15 days 
(Fig. 3B). The reduced in vivo growth rate of 
MCA4-deficient parasites could be partially 
restored by the re-expression of MCA4, with 
75 % of mice succumbing to Δmca4:MCA4 
infection by day 7. Axenic culture of 
parasites isolated from mice at the first peak 
of parasitemia revealed normal growth for 
all strains (Fig. S3) indicating the variation 
observed in vivo was due to interaction with 
the host. 
Detailed analysis of the parasitemia 
patterns of the infected mice revealed 
several interesting trends. The wild type 
parasites were extremely virulent and the 
parasitemia increased very rapidly (Fig. 3C). 
In contrast, mice infected with Δmca4 had a 
peak of parasitemia separated by a trough 
period where parasitemia was below the 
detection threshold.  In the re-expression cell 
lines, the parasitemia profile was more 
similar to that of the wild type cells, typified 
by consistent growth with only one mouse 
per group being able to very briefly clear 
infection to below the detection threshold 
(Fig. 3C). 
MCA4 associates with the flagellar 
membrane - The cellular localisation of 
MCA4 was revealed by 
immunofluorescence microscopy using 
affinity-purified, anti-MCA4 antibody (Fig. 
4A). MCA4 was found to localise 
predominantly to the flagellum, appearing as 
a combination of punctate structures and 
larger confluent foci distributed along the 
entire length of the flagellum. This was 
confirmed by re-expression of MCA4 with a 
C-terminal yellow fluorescent protein (YFP) 
fusion in Δmca4 parasites, which also 
revealed a distinct flagellum localisation 
when viewed by direct fluorescent 
microscopy. Immunogold transmission 
electron microscopy studies provided further 
detailed evidence supporting the punctate 
nature of MCA4 along the flagellum, with 
the enhanced immunogold particles 
appearing in clusters at unmarked but 
distinct foci along the internal surface of the 
flagellum (Fig. 4B). 
The T. brucei flagellum is a complex 
organelle composed of multiple distinct 
structures. To gain potential insights into 
MCA4 function, the precise location within 
the flagellum was assessed using a 
subcellular fractionation procedure capable 
of distinguishing between soluble, 
cytoskeletal and membrane-associated 
proteins. Western blot analysis of T. brucei 
subcellular fractions demonstrated that 
MCA4 was a membrane-associated protein, 
being found in the pellet of the hypotonic 
and sonicated cell lysate and the soluble 
fraction of the detergent treated cell lysate 
(Fig. 5A). To verify the quality of the 
fractionation procedure, the different 
fractions were probed with antibodies 
specific to the cytoskeletal protein β-tubulin 
and the cytoplasmic protein oligopeptidase 
B. To determine whether MCA4 was located 
on the internal or external surface of the 
flagellar membrane, immunofluorescence 
microscopy was performed in the presence 
and absence of Triton X-100 (Fig. 4A). The 
stronger staining of the flagellum was 
detected in those cells treated with detergent, 
suggesting that the MCA4 epitopes were 
mainly internally located and required 
permeabilisation for exposure. 
No single flagellar-targeting 
sequence has been identified for T. brucei, 
however dual acylation has been shown to 
influence the flagellar membrane association 
of several proteins (28,34,35). Previous 
comprehensive bioinformatic screens 
identified MCA4 Gly-2 as a target for N-
myristoylation (36), a modification often 
associated with palmitoylation. Accordingly 
we attempted to provide experimental 
evidence of in vivo MCA4 palmitoylation 
using an acyl-biotin exchange reaction (28). 
Western blotting of material from the 
experimental and control reactions revealed 
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that MCA4 was purified in a 
hydroxylamine-dependent manner from T. 
brucei cell lysate, confirming the protein 
was palmitoylated in vivo (Fig. 5B). This 
experimental finding combined with the 
bioinformatic predictions suggests that 
MCA4 is dually acylated. 
The influence of acylation on MCA4 
localisation was investigated by creation of a 
MCA4G2A mutation that was predicted to 
prevent N-myristoylation and consequently 
palmitoylation.  MCA4G2A was re-expressed 
in Δmca4 parasites and fractionation of the 
Δmca4:MCA4G2A parasites revealed that 
MCA4G2A appeared in the soluble material 
following hypotonic lysis (Fig. 5A). 
Immunofluorescent analysis of the 
Δmca4:MCA4G2A mutants showed that 
MCA4G2A was dispersed throughout the 
cytoplasm and absent from the flagellum 
(Fig. 4A). Infection of mice with 
Δmca4:MCA4G2A parasites demonstrated 
complementation of the Δmca4 phenotype, 
indicating that under the condition tested 
flagellar membrane localisation of MCA4 is 
not essential for an effect on the parasite’s 
virulence (Figs 3B, 3C). 
Processing of MCA4 and release - 
Previous work identified MCA4 as part of 
the secretome of two independent T. brucei 
gambiense strains (37). We therefore tried to 
provide independent verification of a similar 
occurrence in T. brucei. Cultured mid-log 
phase bloodstream form parasites were 
incubated in serum-free medium for 3.5 
hours before removal by centrifugation. The 
resulting parasite-free medium was 
concentrated and analysed alongside whole 
cell lysate by western blot. MCA4 was 
clearly evident in the released material, 
appearing as different sized proteins; a 
higher molecular mass species (identical in 
size to the protein detected in cell lysate) and 
two smaller less abundant processed forms 
(Fig. 6A). Non-specific protein 
accumulation in the medium was analysed 
by probing the blot with anti-Bip which is 
largely retained intracellularly (38). In 
comparison to the parasite lysate, only small 
amounts of Bip were detected in the released 
material (Fig. 6A). MCA4 release was 
detected in both Δmca4:MCA4 and 
Δmca4:MCA4G2A cell lines, revealing MCA4 
release occurred independent of flagellar 
membrane localisation (Fig. 6A). One key 
finding, however, was the absence of any 
processed MCA4 protein in the material 
released from Δmca4:MCA4G2A cells. This 
excluded the possibility of random 
degradation of MCA4 occurring in the 
medium and suggested a specific proteolytic 
event dependent upon association of MCA4 
with the flagellar membrane. 
To test if one of the other TbMCAs 
might be responsible for MCA4 processing, 
we analysed material released from ∆mca2/3 
∆mca5 parasites (16) and found that only 
full length MCA4 could be detected. We 
analysed individual re-expressor cell lines 
and identified MCA3 as the major peptidase 
responsible for MCA4 processing (Fig. 6A). 
MCA2 and MCA3 proteins share 89% 
sequence identity with near identical 
catalytic domains and divergence only found 
at the N-terminus (15,16), a  difference that 
does not appear to alter the enzyme’s 
substrate specificity (Fig. S4). Thus it was 
intriguing that in vivo processing of MCA4 
was mediated only by MCA3. To rule out 
the possibility that MCA4 is resistant to 
MCA2 proteolytic activity we incubated 
recombinant MCA4 with MCA2 (2:1 molar 
ratio) and, having confirmed that it had no 
significant impact on MCA2 activity, 
showed that recombinant MCA2 processed 
MCA4 with a similar pattern of cleavage as 
the autocatalytic processing by MCA4S219C 
(compare Figs 6B and 1B). N-terminal 
Edman degradation revealed that processing 
occurred at Lys64, the same residue cleaved 
during autocatalytic processing of 
recombinant MCA4S219C (Figs 1B and 6B). 
These data suggest that the selective in vivo 
proteolytic cleavage of MCA4 by MCA3  
must be due to reasons other than specificity 
per se and provide direct evidence that there 
is co-localisation of and interaction between 
these T. brucei MCAs in a proteolytic 
cascade resulting in release of the 
pseudopeptidase. 
 
DISCUSSION 
The active site residues of 
metacaspases have been identified through 
sequence alignment and homology with 
caspases, followed in some cases by 
experimental verification (2,4). The 
predicted active site of MCA4 is of 
particular interest due to the presence of a 
potential serine nucleophile within a 
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cysteine peptidase. Here we demonstrate, 
however, that MCA4 does not have 
autocatalytic activity, or activity towards a 
range of peptide substrates, ruling out the 
possibilities that it functions as a mixed type 
peptidase or that catalytic activity can be 
derived from other conserved cysteine 
residues. Nevertheless, by using mutagenesis 
to reinstate a canonical-metacaspase active 
site we have shown that MCA4S219C has 
calcium-dependent MCA-like activity and 
consequently the native protein has retained 
a functional peptidase tertiary structure. In 
light of these findings, we speculate that the 
active site cysteine was mutated in an 
ancestral MCA, generating the 
pseudopeptidase MCA4, which now fulfils 
an important role for the parasite. 
Targeted RNAi down-regulation 
indicated that MCA4 is essential for 
bloodstream form cell proliferation. At 24 
hours post-induction, abnormal cell types 
accumulated which is indicative of a post-
mitotic block and links MCA4 to a role in 
cytokinesis. However, the MCA4 RNAi 
mutants broadly conform to a common 
phenotype associated with the RNAi down-
regulation of key bloodstream form flagellar 
proteins (39). Therefore, given the flagellar 
membrane association that we have 
demonstrated for MCA4, we predict that 
MCA4 is more likely to exert its effect on 
cytokinesis indirectly. 
The implied essentiality of MCA4 
following RNAi down-regulation strongly 
suggested that the gene would be refractory 
to genetic deletion. However, MCA4 was 
successfully deleted from bloodstream form 
cells creating viable null mutant parasites 
(Δmca4). We attribute this apparent 
discrepancy to the differing dynamics of 
MCA4 depletion associated with each 
technique. RNAi of MCA4 leads to rapid 
removal of the protein preventing parasite 
adaptation, whereas the sequential 
replacement of each allele during creation of 
the null mutants provides sufficient time for 
parasite adjustment to diminishing MCA4 
levels. This adaptation in null mutants has 
also been described for Δmca2/3Δmca5 
parasites (16). In that instance, it was 
suggested that MCA4 may be an alternative 
compensatory biochemical pathway 
following the deletion of MCA2, MCA3 and 
MCA5. However, given the absence of 
MCA4 activity and the markedly different 
localisation this now appears unlikely. 
The ancestral MCA homologue in T. 
brucei is likely to be MCA5, given its 
synteny with the single L. major MCA. This 
raises the question of whether MCA function 
differs between organisms with a single 
metacaspase (such as budding yeast and L. 
major) and organisms with multiple MCAs 
(T. brucei and A. thaliana). MCA2, MCA3 
and MCA4 are all expressed at a higher level 
in the bloodstream form of the parasite than 
in the procyclic form, whereas MCA5 is 
expressed equally in both life cycle stages 
((16) and this study). Accordingly, we 
speculated that MCA4 could be involved in 
trypanosome-specific functions associated 
with mammalian infectivity. Indeed, 
infection of mice with wild type T. brucei 
and ∆mca4 cell lines revealed strikingly 
different patterns of infection; with ∆mca4 
cells showing periods below the detection 
threshold and consecutive days of reduced 
parasite burdens more similar to 
pleomorphic bloodstream form strains than 
to the parental highly virulent monomorphic 
427 strain. This resulted in a markedly 
extended survival time for the host mice and 
revealed a role for MCA4 in parasite 
virulence within the mammalian host.  
Our data, together with a recent 
characterisation of the flagellum proteome 
(40) has identified a flagellum localisation 
for MCA4. Several other flagellar proteins 
have also been shown to influence T. brucei 
virulence in mice. The deletion of the GPI-
phospholipase C created a prolonged 
infection in mice that was accompanied by 
multiple peaks and troughs of parasitemia 
(41). In addition, in vivo RNAi silencing of 
the calflagins (Tb17, Tb24 and Tb44) 
prolonged mouse survival by attenuating 
parasite growth, creating an infection with 
waves of parasitemia associated with the 
expression of alternative variant surface 
glycoproteins (42). Although not confirmed 
experimentally, it seems likely that the 
reduced virulence of ∆mca4 allowed the 
host’s immune system sufficient time to 
clear the original infection before the re-
emergence of cells expressing a different 
VSG type. 
Regulated proteolytic activity is an 
important mechanism of signal transduction 
used by peptidases to modify properties of 
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substrate proteins. The strict specificity 
displayed by many Clan CD peptidases is 
dictated by a highly selective S1 pocket, 
which ensures they are well adapted to carry 
out specific processing events and less suited 
to perform random proteolytic degradation. 
This is well demonstrated by the many 
complex and intricate signalling pathways 
involving caspases during their participation 
in apoptosis and inflammation (43). Indeed, 
related processes have recently been 
reported for a MCA from Picea abies (mcII-
Pa) that was shown to inactivate a tudor 
staphylococcal nuclease (TSN) protein 
through cleavage at four defined sites during 
programmed cell death events associated 
with embryogenesis and oxidative stress (6). 
However, whether this represents a highly 
specific form of signal transduction, as 
witnessed for capsases, is open to some 
debate (8). Our observation that MCA3 
processes MCA4 provides the first 
identification of an in vivo T. brucei MCA 
substrate, which is only the second MCA 
substrate to be identified, after TSN (6). 
While the biological significance of MCA4 
processing is unknown, this cleavage event 
establishes an important link between two 
MCAs that may be a component of a broader 
MCA cascade. Moreover, the proteolytic 
inactivity of MCA4 suggests it lies at the 
end of any such proteolytic cascade. This 
arrangement, whereby MCA4 is placed 
under the control of MCA3, may optimise 
release and action of MCA4 in a highly 
regulated manner. 
The major form of MCA4 detected 
after release from the parasite was similar in 
size to the full length protein, but less 
abundant lower molecular mass forms were 
also detected. As re-expression of MCA4G2A 
in Δmca4 resulted in the release of only the 
full length protein, processing of MCA4 is 
clearly dependent upon correct membrane 
localisation and was not the product of 
random degradation or autocatalytic activity. 
Our finding that MCA3 processes MCA4 is 
particularly relevant as MCA3 has been 
reported to be present in RAB11 positive 
endosomes/exosomes (16) and the flagellum 
proteome (40) and is the only other T. brucei 
MCA that is palmitoylated (35). These data 
suggest that there must be some cross-over 
between the exosome membranes and the 
flagellum, at which point MCA4 is 
processed and released. We have also shown 
that lipidation is crucial in allowing direct 
interaction between MCA3 and MCA4 on 
the membrane. However, this interaction at 
the membrane is not essential for the release 
of MCA4, as the non-lipidated mutant is also 
released, possibly via an alternative route. 
The way in which MCA4 exerts its 
influence upon infection in a mammalian 
host remains to be established, but the recent 
proposal that exosome release, by both 
intracellular and extracellular pathogens, can 
allow effector molecule delivery to host cell 
cytosol (44), provides a possible mechanism 
for delivery of trypanosome virulence 
factors (45). Our finding that MCA4 is 
released by bloodstream form T. brucei and 
does not appear to influence the processing 
or activity of other MCAs, opens up the 
possibility that it could target and regulate 
host molecules. Future investigation of T. 
brucei strains that establish natural chronic 
infections could help identify potential 
MCA4 interactions and allow further 
clarification of its role in parasite virulence.  
11 
 
 at G
lasgow University Library, on O
ctober 7, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
12 
 
REFERENCES 
 
1. Uren, A. G., O'Rourke, K., Aravind, L., Pisabarro, M. T., Seshagiri, S., Koonin, E. V., 
and Dixit, V. M. (2000) Mol Cell 6, 961-967 
2. Moss, C. X., Westrop, G. D., Juliano, L., Coombs, G. H., and Mottram, J. C. (2007) 
FEBS Letts 581, 5635-5639 
3. Watanabe, N. and Lam, E. (2005) J Biol Chem 280, 14691-14699 
4. Vercammen, D., van de Cotte, B., De Jaeger, G., Eeckhout, D., Casteels, P., Vandepoele, 
K., Vandenberghe, I., Van Beeumen, J., Inzé, D., and Van Breusegem, F. (2004) J Biol 
Chem 279, 45329-45336 
5. Bozhkov, P. V., Suarez, M. F., Filonova, L. H., Daniel, G., Zamyatnin, A. A., Rodriguez-
Nieto, S., Zhivotovsky, B., and Smertenko, A. (2005) Proc Natl Acad Sci USA 102, 
14463-14468 
6. Sundstrom, J. F., Vaculova, A., Smertenko, A. P., Savenkov, E. I., Golovko, A., Minina, 
E., Tiwari, B. S., Rodriguez-Nieto, S., Zamyatnin, A. A., Valineva, T., Saarikettu, J., 
Frilander, M. J., Suarez, M. F., Zavialov, A., Stahl, U., Hussey, P. J., Silvennoinen, O., 
Sundberg, E., Zhivotovsky, B., and Bozhkov, P. V. (2009) Nat Cell Biol 11, 1347-1354 
7. Madeo, F., Herker, E., Maldener, C., Wissing, S., Lächelt, S., Herlan, M., Fehr, M., 
Lauber, K., Sigrist, S. J., Wesselborg, S., and Fröhlich, K. U. (2002) Mol Cell 9, 911-917 
8. Tsiatsiani, L., Van Breusegem, F., Gallois, P., Zavialov, A., Lam, E., and Bozhkov, P. V. 
(2011) Cell Death Differ 18, 1279-1288 
9. Lee, R. E. C., Puente, L. G., Kaern, M., and Megeney, L. A. (2008) Plos One 3, e2956 
10. Lee, R. E. C., Brunette, S., Puente, L. G., and Megeney, L. A. (2010) Proc Natl Acad Sci 
USA 107, 13348-13353 
11. Ambit, A., Fasel, N., Coombs, G. H., and Mottram, J. C. (2007) Cell Death Differ 15, 
113-122 
12. Zalila, H., Gonzalez, I. J., El Fadili, A. K., Delgado, M. B., Desponds, C., Schaff, C., and 
Fasel, N. (2011) Mol Microbiol 79, 222-239 
13. Coll, N. S., Vercammen, D., Smidler, A., Clover, C., Van Breusegem, F., Dangl, J. L., 
and Epple, P. (2010) Science 330, 1393-1397 
14. Szallies, A., Kubata, B. K., and Duszenko, M. (2002) FEBS Letts 517, 144-150 
15. Mottram, J. C., Helms, M. J., Coombs, G. H., and Sajid, M. (2003) Trends Parasitol 19, 
182-187 
16. Helms, M. J., Ambit, A., Appleton, P., Tetley, L., Coombs, G. H., and Mottram, J. C. 
(2006) J Cell Sci 119, 1105-1117 
17. Pils, B. and Schultz, J. (2004) J Mol Biol 340, 399-404 
18. Yu, J. W., Jeffrey, P. D., and Shi, Y. (2009) Proc Natl Acad Sci USA 106, 8169-8174 
19. Zettl, M., Adrain, C., Strisovsky, K., Lastun, V., and Freeman, M. (2011) Cell 145, 79-91 
20. Sarkany, Z. and Polgar, L. (2003) Biochemistry 42, 516-522 
21. LaCount, D. J., Bruse, S., Hill, K. L., and Donelson, J. E. (2000) Mol Biochem Parasitol 
111, 67-76 
22. Kelly, S., Reed, J., Kramer, S., Ellis, L., Webb, H., Sunter, J., Salje, J., Marinsek, N., 
Gull, K., Wickstead, B., and Carrington, M. (2007) Mol Biochem Parasitol 154, 103-109 
23. Wirtz, E., Leal, S., Ochatt, C., and Cross, G.A. (1999) Mol Biochem Parasitol 99, 89-101 
24. Birkett, C. R., Foster, K. E., Johnson, L., and Gull, K. (1985) FEBS Letts 187, 211-218 
25. Burleigh, B. A., Caler, E. V., Webster, P., and Andrews, N. W. (1997) J Cell Biol 136, 
609-620 
26. Morty, R. E., Lonsdale-Eccles, J. D., Mentele, R., Auerswald, E. A., and Coetzer, T. H. T. 
(2001) Infect Immun 69, 2757-2761 
27. Munday, J. C., McLuskey, K., Brown, E., Coombs, G. H., and Mottram, J. C. (2011) Mol 
Biochem Parasitol 175, 49-57 
28. Emmer, B. T., Souther, C., Toriello, K. M., Olson, C. L., Epting, C. L., and Engman, D. 
M. (2009) J Cell Sci 122, 867-874 
29. Field, M. C., Allen, C. L., Dhir, V., Goulding, D., Hall, B. S., Morgan, G. W., Veazey, P., 
and Engstler, M. (2004) Microsc Microanal 10, 621-636 
 at G
lasgow University Library, on O
ctober 7, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
30. Liu, W., Apagyi, K., McLeavy, L., and Ersfeld, K. (2010) Mol Biochem Parasitol 169, 
20-26 
31. Bastin, P., Pullen, T. J., Sherwin, T., and Gull, K. (1999) J Cell Sci 112, 3769-3777 
32. Belenghi, B., Romero-Puertas, M. C., Vercammen, D., Brackenier, A., Inzé, D., 
Delledonne, M., and Van Breusegem, F. (2007) J Biol Chem 282, 1352-1358 
33. Alsford, S., Turner, D. J., Obado, S. O., Sanchez-Flores, A., Glover, L., Berriman, M., 
Hertz-Fowler, C., and Horn, D. (2011) Genome Res 21, 915-924 
34. Absalon, S., Blisnick, T., Kohl, L., Toutirais, G., Dore, G., Julkowska, D., Tavenet, A., 
and Bastin, P. (2008) Mol Biol Cell 19, 929-944 
35. Emmer, B. T., Nakayasu, E. S., Souther, C., Choi, H., Sobreira, T. J. P., Epting, C. L., 
Nesvizhskii, A. I., Almeida, I. C., and Engman, D. M. (2011) Eukaryot Cell 10, 455-463 
36. Mills, E., Price, H. P., Johner, A., Emerson, J. E., and Smith, D. F. (2007) Mol Biochem 
Parasitol 152, 22-34 
37. Geiger, A., Hirtz, C., Becue, T., Bellard, E., Centeno, D., Gargani, D., Rossignol, M., 
Cuny, G., and Peltier, J. B. (2010) BMC Microbiol 10, 20 
38. Bangs, J. D., Brouch, E. M., Ransom, D. M., and Roggy, J. L. (1996) J Biol Chem 271, 
18387-18393 
39. Broadhead, R., Dawe, H. R., Farr, H., Griffiths, S., Hart, S. R., Portman, N., Shaw, M. K., 
Ginger, M. L., Gaskell, S. J., Mckean, P. G., and Gull, K. (2006) Nature 440, 224-227 
40. Oberholzer, M., Langousis, G., Nguyen, H. T., Saada, E. A., Shimogawa, M. M., Jonsson, 
Z. O., Nguyen, S. M., Wohlschlelgel, J. A., and Hill, K. L. (2011) Mol Cell Proteomics In 
press, 
41. Webb, H., Carnall, N., Vanhamme, L., Rolin, S., Abbeele, J. V. D., Welburn, S., Pays, E., 
and Carrington, M. (1997) J Cell Biol 139, 103-114 
42. Emmer, B. T., Daniels, M. D., Taylor, J. M., Epting, C. L., and Engman, D. M. (2010) 
Eukaryot Cell 9, 934-942 
43. Pop, C. and Salvesen, G. S. (2009) J Biol Chem 284, 21777-21781 
44. Silverman, J. M. and Reiner, N. E. (2011) Cell Microbiol 13, 1-9 
45. Grébaut, P., Chuchana, P., Brizard, J. P., Demettre, E., Seveno, M., Bossard, G., Jouin, P., 
Vincendeau, P., Bengaly, Z., Boulangé A., Cuny, G., and Holzmuller, P. (2009) Int J 
Parasitol 39, 1137-1150 
 
Acknowledgements. We thank Karen McLuskey for critical reading of the manuscript. 
 
FOOTNOTES 
 
This work was supported by the Medical Research Council (grant numbers G9722968, 
G0000508 and G0700127). 
 
Abbreviations: MCA, metacaspase; TSN, tudor staphylococcal nuclease; mcII-Pa, 
Picea abies metacaspase; Yca1, S. cerevisiae metacaspase; cFLIPL, cellular FLICE-
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FIGURE LEGENDS 
 
FIGURE 1. MCA4 and MCA4S219C peptidase activity. (A) Lack of calcium dependent MCA4 
autoprocessing (10 μg) was analysed by SDS-PAGE. (B) Calcium dependent MCA4S219C 
(10μg) autoprocessing was analysed by SDS-PAGE. The N-terminus of the major processed 
product was sequenced and the processing site marked with an asterisk. (C) Cleavage of Z-
GGR-AMC by 5 μg MCA4S219C was measured in conditions indicated, expressed as relative 
value and given as mean ± standard deviation.  
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FIGURE 2. MCA4 expression and analysis by RNAi. (A) Total cell lysates were prepared 
from T. brucei bloodstream form (lane 1) and procyclic form (lane 2) and bloodstream form 
Δmca2/3Δmca5 (lane 3) and separated by SDS-PAGE before western blotting with anti-
MCA4. An antibody specific to EF-1α demonstrates equal loading. (B) MCA4 RNAi in 
bloodstream form was induced by 1 μg ml-1 tetracycline (Tet+) and parasite growth rate 
compared to non-induced control (Tet-). (C) Western blot analysis of MCA4 protein level 
during RNAi time course. (D) The effect of MCA4 RNAi on cell cycle progression was 
determined by assessing DNA configuration using DAPI staining and fluorescence 
microscopy. >200 cells were counted per time point. Cells at the start of the cycle with a 
single nucleus (N) and kinetoplast (K) are 1N1K. Kinetoplast division occurs ahead of 
nuclear division, leading to 1N2K cells before post mitotic 2N2K cells. Those cells with 
abnormal DNA content classified as ‘other’. 
 
FIGURE 3. Analysis of bloodstream form MCA4 null mutants. (A) Western blot of ∆mca4 
and re-expression cell lines. Lane 1, T. brucei 427; Lane 2, ∆mca4; Lane 3, ∆mca4:MCA4; 
Lane 4, ∆mca4:MCA4G2A; Lane 5 ∆mca4:MCA4S219C. (B) Groups of 4 mice were infected 
with 3 x 105 parasites (2 mice for wild type parasites) and mouse survival was monitored 
daily and is shown by a Kaplan-Meier survival curve. (C) Mice were infected with 3 x105 
parasites and parasitemia was monitored by tail prick and haemocytometer cell count. Mice 
were culled when parasitemia reached >1  x 108 cells ml-1 or upon presentation of severe 
symptoms.  
 
FIGURE 4. Localisation of MCA4 in bloodstream form trypanosomes. (A) 
Immunofluorescence. Cells were permeabilized with Triton X-100 or left intact, before 
incubation with anti-MCA4 antibody and anti-chicken Alexa Fluor 488 conjugate, visualised 
using FITC filter set (green). DNA stained with DAPI (blue) and reference images taken with 
differential interference contrast (DIC) filter settings. Scale bars 5 µm. (B) MCA4 
immunogold transmission electron microscopy. Fixed cells were cryosectioned and labelled 
with anti-MCA4 and 1.4 nm gold conjugated rabbit anti-chicken. Black arrowheads show 
enhanced immunogold particles. Lower left image represent digitally magnified section of the 
corresponding image above, arrow head labelled a and b are labelled a’ and b’ on magnified 
section. 
 
FIGURE 5. Subcellular fractionation and modification of MCA4 in bloodstream form 
trypanosomes. (A) Cell fractionation. Total cell lysate (T), detergent soluble (DS), detergent 
pellet (DP), hypotonic soluble (HS) and hypotonic pellet (HP) fractions were analysed by 
western blot using anti-MCA4 antibody. Quality of fractionation was validated with 
antibodies specific to β-tubulin and OPB. (B) Acyl-biotin exchange reaction. Palmitoylated 
proteins were specifically labelled by cleaving palmitate-thioester bonds with hydroxylamine 
and subsequently reacted with biotin-HPDP allowing purification with streptavidin agarose. 
Original cell lysate (I), the wash fraction (W) and eluted material (E) from hydroxylamine 
treated and Tris control samples were immunoblotted with anti-MCA4 antibody. 
 
FIGURE 6. MCA4 release and proteolytic processing by MCA3 (A) Detection of MCA4 in 
released material. Cells were incubated in serum free medium then removed by centrifugation 
before concentration of cell free fraction and analysis by western blot. Total cell lysate (T) 
and released material (R) was probed with anti-MCA4. The blot was stripped and reprobed 
with anti-Bip. (B) MCA4 processing by MCA2 was analysed by SDS-PAGE. The N-terminus 
of the major processed product was sequenced and six amino acids were identified 
(underlined) and the cleavage site marked with an asterisk. RB; reaction buffer. 
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